Q4 2014

Source filing unavailable

Q4 2014 · —

derived · Computed from the longer spans the company filed.

Revenue

$229.40M

derived+56.2% vs Q4 2013

Net Income

-$69.80M

derivedN/M vs Q4 2013

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Incomederived-$58,756,000N/M

Same quarter

Metric	Q4 2014derived from reported figures	Q4 2013derived from reported figures	Q4 2012derived from reported figures	Q4 2011derived from reported figures
Revenue	$229.40M	$146.87M	$131.94M	$107.85M
Net Income	-$69.80M	-$61.99M	-$53.01M	-$26.74M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR